FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 mutation as detected by an FDA-approved test
0:00
3:00
Listen to a soundcast of the August 25, 2021 FDA approval of Tibsovo (ivosidenib) for adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 mutation as detected by an FDA-approved test
Mais episódios de "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
Não percas um episódio de “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” e subscrevê-lo na aplicação GetPodcast.